Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A by Harris, SA, Satti, I, Matsumiya, M, Stockdale, L, Chomka, A, Tanner, R, O'Shea, MK, Thomas, Z-R, Tameris, M, Mahomed, H, Scriba, TJ, Hanekom, WA, Fletcher, HA, McShane, H

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated... by Sheehan, S, Harris, SA, Satti, I, Hokey, DA, Dheenadhayalan, V, Stockdale, L, Thomas, Z-R, Minhinnick, A, Wilkie, M, Vermaak, S, Meyer, J, O'Shea, MK, Pau, MG, Versteege, I, Douoguih, M, Hendriks, J, Sadoff, J, Landry, B, Moss, P, McShane, H

Cytomegalovirus infection is a risk factor for TB disease in infants by Müller, J, Tanner, R, Matsumiya, M, Snowden, MA, Landry, B, Satti, I, Harris, SA, O'Shea, MK, Stockdale, L, Marsay, L, Chomka, A, Harrington-Kandt, R, Thomas, Z-R, Stylianou, E, Naranbhai, V, Mbandi, SK, Hatherill, M, Hussey, G, Mahomed, H, Tameris, M, McClain, JB, Hanekom, WA, Evans, TG, Scriba, TJ, McShane, H